KMPHARMACEUTICAL Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	350.62	221.05	953.37	447.75	2,131
Short-Term Investments	-	-	70.5	150	235
Trading Asset Securities	-	588.92	-	-	330.1
Cash & Short-Term Investments	350.62	809.97	1,024	597.75	2,697
Cash Growth	-56.71%	-20.89%	71.29%	-77.83%	-54.13%
Accounts Receivable	1,170	1,235	1,594	2,260	3,577
Other Receivables	45.45	85.26	739.44	14.15	175.58
Receivables	1,216	1,321	2,333	2,274	3,753
Inventory	2,018	2,424	2,385	2,453	2,759
Prepaid Expenses	154.09	140.81	202.27	256.78	591.69
Other Current Assets	31.23	21.55	37.19	763.4	45.81
Total Current Assets	3,770	4,717	5,982	6,345	9,846
Property, Plant & Equipment	20,415	21,096	21,183	22,325	25,009
Long-Term Investments	6,756	7,417	5,503	4,648	4,202
Other Intangible Assets	20.21	14.24	29.41	67.68	105.7
Long-Term Accounts Receivable	60.36	-	-	-	-
Long-Term Deferred Tax Assets	-	-	775.7	1,258	720.28
Other Long-Term Assets	7,227	7,305	8,220	8,307	7,794
Total Assets	46,393	48,973	50,555	51,281	52,676
Accounts Payable	1,249	998.73	802.07	636.39	1,269
Accrued Expenses	827.95	856.86	1,275	603.13	898.07
Short-Term Debt	4,800	4,000	6,000	2,500	1,000
Current Portion of Long-Term Debt	4,833	3,136	3,272	8,272	3,367
Current Portion of Leases	-	-	39.08	51.69	51.69
Current Income Taxes Payable	-	-	-	-	26.12
Current Unearned Revenue	14.62	14.62	0.58	12.57	32.51
Other Current Liabilities	173.74	309.97	493.55	422.68	828.16
Total Current Liabilities	11,898	9,316	11,882	12,498	7,473
Long-Term Debt	6,167	7,000	3,136	2,408	5,180
Long-Term Leases	-	-	-	36.58	82.62
Other Long-Term Liabilities	61.84	41.94	59.08	10.15	34.32
Total Liabilities	18,127	16,358	15,077	14,953	12,770
Common Stock	2,789	2,789	2,789	2,789	2,789
Additional Paid-In Capital	10,911	42,562	42,562	42,562	42,562
Retained Earnings	13,648	-14,035	-9,462	-8,142	-4,217
Treasury Stock	-0.17	-0.17	-0.17	-0.17	-0.17
Comprehensive Income & Other	918.59	1,299	-410.63	-881.32	-1,228
Shareholders' Equity	28,266	32,615	35,479	36,328	39,906
Total Liabilities & Equity	46,393	48,973	50,555	51,281	52,676
Total Debt	15,800	14,136	12,447	13,268	9,681
Net Cash (Debt)	-15,449	-13,326	-11,423	-12,671	-6,985
Net Cash Per Share	-552.86	-477.87	-409.62	-455.17	-251.42
Filing Date Shares Outstanding	28.12	27.89	27.89	27.89	27.89
Total Common Shares Outstanding	28.12	27.89	27.89	27.89	27.89
Working Capital	-8,128	-4,599	-5,900	-6,153	2,373
Book Value Per Share	1005.34	1169.54	1272.23	1302.68	1430.99
Tangible Book Value	28,246	32,601	35,449	36,260	39,800
Tangible Book Value Per Share	1004.62	1169.03	1271.17	1300.26	1427.20
Land	13,707	13,707	12,985	12,985	13,045
Buildings	6,516	6,516	6,374	6,374	6,886
Machinery	6,339	6,013	5,883	5,936	6,736
Construction In Progress	5.05	96.25	15.28	11.53	12.52

Source: S&P Global Market Intelligence. Standard template. Financial Sources.